Physicians discuss use of new guidelines on aromatase inhibitor to prevent breast can

[News]

The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women.

More... (http://www.news-medical.net/news/20130710/Physicians-discuss-use-of-new-guidelines-on-aromatase-inhibitor-to-prevent-breast-cancer.aspx)

[karen z]

Very interesting post.